speb/financial-data huggingface dataset:
CSCO.TO balance_sheet (annual, 2025-07-31) — Pensionand Other Post Retirement Benefit Plans Current: 3611000000.00
CSCO.TO balance_sheet (quarterly, 2025-07-31) — Pensionand Other Post Retirement Benefit Plans Current: 3611000000.00
CSCO.TO balance_sheet (annual, 2025-07-31) — Preferred Stock: 0.00
CSCO.TO balance_sheet (quarterly, 2025-07-31) — Preferred Stock: 0.00
CSCO.TO income_statement (annual, 2025-07-31) — Pretax Income: 11100000000.00
CSCO.TO income_statement (quarterly, 2025-07-31) — Pretax Income: 2999000000.00
CSCO.TO balance_sheet (annual, 2025-07-31) — Properties: 4045000000.00
CSCO.TO balance_sheet (quarterly, 2025-07-31) — Properties: 4045000000.00
CSCO.TO cash_flow (annual, 2025-07-31) — Provisionand Write Offof Assets: 24000000.00
CSCO.TO cash_flow (quarterly, 2025-07-31) — Provisionand Write Offof Assets: 7000000.00
CSCO.TO cash_flow (annual, 2025-07-31) — Purchase Of Business: -291000000.00
CSCO.TO cash_flow (quarterly, 2025-07-31) — Purchase Of Business: 0.00
CSCO.TO cash_flow (annual, 2025-07-31) — Purchase Of Investment: -4972000000.00
CSCO.TO cash_flow (quarterly, 2025-07-31) — Purchase Of Investment: -1641000000.00
CSCO.TO cash_flow (annual, 2025-07-31) — Purchase Of PPE: -905000000.00
CSCO.TO cash_flow (quarterly, 2025-07-31) — Purchase Of PPE: -217000000.00
CSCO.TO balance_sheet (annual, 2025-07-31) — Raw Materials: 1964000000.00
CSCO.TO balance_sheet (quarterly, 2025-07-31) — Raw Materials: 1964000000.00
CSCO.TO balance_sheet (annual, 2025-07-31) — Receivables: 9762000000.00
CSCO.TO balance_sheet (quarterly, 2025-07-31) — Receivables: 9762000000.00
CSCO.TO income_statement (annual, 2025-07-31) — Reconciled Cost Of Revenue: 18081000000.00
CSCO.TO income_statement (quarterly, 2025-07-31) — Reconciled Cost Of Revenue: 5012000000.00
CSCO.TO income_statement (annual, 2025-07-31) — Reconciled Depreciation: 2811000000.00
CSCO.TO income_statement (quarterly, 2025-07-31) — Reconciled Depreciation: 635000000.00
CSCO.TO cash_flow (annual, 2025-07-31) — Repayment Of Debt: -22073000000.00
CSCO.TO cash_flow (quarterly, 2025-07-31) — Repayment Of Debt: -3528000000.00
CSCO.TO cash_flow (annual, 2025-07-31) — Repurchase Of Capital Stock: -7222000000.00
CSCO.TO cash_flow (quarterly, 2025-07-31) — Repurchase Of Capital Stock: -1564000000.00
CSCO.TO income_statement (annual, 2025-07-31) — Research And Development: 9300000000.00
CSCO.TO income_statement (quarterly, 2025-07-31) — Research And Development: 2380000000.00
CSCO.TO income_statement (annual, 2025-07-31) — Restructuring And Mergern Acquisition: 744000000.00
CSCO.TO income_statement (quarterly, 2025-07-31) — Restructuring And Mergern Acquisition: 35000000.00
CSCO.TO balance_sheet (annual, 2025-07-31) — Retained Earnings: 50000000.00
CSCO.TO balance_sheet (quarterly, 2025-07-31) — Retained Earnings: 50000000.00
CSCO.TO cash_flow (annual, 2025-07-31) — Sale Of Investment: 7892000000.00
CSCO.TO cash_flow (quarterly, 2025-07-31) — Sale Of Investment: 1571000000.00
CSCO.TO income_statement (annual, 2025-07-31) — Selling And Marketing Expense: 10966000000.00
CSCO.TO income_statement (quarterly, 2025-07-31) — Selling And Marketing Expense: 2818000000.00
CSCO.TO income_statement (annual, 2025-07-31) — Selling General And Administration: 13958000000.00
CSCO.TO income_statement (quarterly, 2025-07-31) — Selling General And Administration: 3524000000.00
CSCO.TO balance_sheet (annual, 2025-07-31) — Share Issued: 3959998180.00
CSCO.TO balance_sheet (quarterly, 2025-07-31) — Share Issued: 3959998180.00
CSCO.TO income_statement (annual, 2025-07-31) — Special Income Charges: -744000000.00
CSCO.TO income_statement (quarterly, 2025-07-31) — Special Income Charges: -35000000.00
CSCO.TO cash_flow (annual, 2025-07-31) — Stock Based Compensation: 3641000000.00
CSCO.TO cash_flow (quarterly, 2025-07-31) — Stock Based Compensation: 948000000.00
CSCO.TO balance_sheet (annual, 2025-07-31) — Stockholders Equity: 46843000000.00
CSCO.TO balance_sheet (quarterly, 2025-07-31) — Stockholders Equity: 46843000000.00
CSCO.TO balance_sheet (annual, 2025-07-31) — Tangible Book Value: -21468000000.00
CSCO.TO balance_sheet (quarterly, 2025-07-31) — Tangible Book Value: -21468000000.00
CSCO.TO income_statement (annual, 2025-07-31) — Tax Effect Of Unusual Items: -54946000.00
CSCO.TO income_statement (quarterly, 2025-07-31) — Tax Effect Of Unusual Items: 8384128.04
CSCO.TO income_statement (annual, 2025-07-31) — Tax Provision: 920000000.00
CSCO.TO income_statement (quarterly, 2025-07-31) — Tax Provision: 449000000.00
CSCO.TO income_statement (annual, 2025-07-31) — Tax Rate For Calcs: 0.08
CSCO.TO income_statement (quarterly, 2025-07-31) — Tax Rate For Calcs: 0.15
CSCO.TO balance_sheet (annual, 2025-07-31) — Total Assets: 122291000000.00
CSCO.TO balance_sheet (quarterly, 2025-07-31) — Total Assets: 122291000000.00
CSCO.TO balance_sheet (annual, 2025-07-31) — Total Capitalization: 69704000000.00
CSCO.TO balance_sheet (quarterly, 2025-07-31) — Total Capitalization: 69704000000.00
CSCO.TO balance_sheet (annual, 2025-07-31) — Total Debt: 28093000000.00
CSCO.TO balance_sheet (quarterly, 2025-07-31) — Total Debt: 28093000000.00
CSCO.TO balance_sheet (annual, 2025-07-31) — Total Equity Gross Minority Interest: 46843000000.00
CSCO.TO balance_sheet (quarterly, 2025-07-31) — Total Equity Gross Minority Interest: 46843000000.00
CSCO.TO income_statement (annual, 2025-07-31) — Total Expenses: 44150000000.00
CSCO.TO income_statement (quarterly, 2025-07-31) — Total Expenses: 11551000000.00
CSCO.TO balance_sheet (annual, 2025-07-31) — Total Liabilities Net Minority Interest: 75448000000.00
CSCO.TO balance_sheet (quarterly, 2025-07-31) — Total Liabilities Net Minority Interest: 75448000000.00
CSCO.TO balance_sheet (annual, 2025-07-31) — Total Non Current Assets: 87305000000.00
CSCO.TO balance_sheet (quarterly, 2025-07-31) — Total Non Current Assets: 87305000000.00
CSCO.TO balance_sheet (annual, 2025-07-31) — Total Non Current Liabilities Net Minority Interest: 40384000000.00
CSCO.TO balance_sheet (quarterly, 2025-07-31) — Total Non Current Liabilities Net Minority Interest: 40384000000.00
CSCO.TO income_statement (annual, 2025-07-31) — Total Operating Income As Reported: 11760000000.00
CSCO.TO income_statement (quarterly, 2025-07-31) — Total Operating Income As Reported: 3087000000.00
CSCO.TO balance_sheet (annual, 2025-07-31) — Total Tax Payable: 1857000000.00
CSCO.TO balance_sheet (quarterly, 2025-07-31) — Total Tax Payable: 1857000000.00
CSCO.TO income_statement (annual, 2025-07-31) — Total Unusual Items: -662000000.00
CSCO.TO income_statement (quarterly, 2025-07-31) — Total Unusual Items: 56000000.00
CSCO.TO income_statement (annual, 2025-07-31) — Total Unusual Items Excluding Goodwill: -662000000.00
CSCO.TO income_statement (quarterly, 2025-07-31) — Total Unusual Items Excluding Goodwill: 56000000.00
CSCO.TO balance_sheet (annual, 2025-07-31) — Tradeand Other Payables Non Current: 2165000000.00
CSCO.TO balance_sheet (quarterly, 2025-07-31) — Tradeand Other Payables Non Current: 2165000000.00
CSCO.TO balance_sheet (annual, 2025-07-31) — Work In Process: 261000000.00
CSCO.TO balance_sheet (quarterly, 2025-07-31) — Work In Process: 261000000.00
CSCO.TO balance_sheet (annual, 2025-07-31) — Working Capital: -78000000.00
CSCO.TO balance_sheet (quarterly, 2025-07-31) — Working Capital: -78000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — +Operating Expense: 6235000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — +Total Revenue: 14883000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 2418000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Accounts Receivable: 4827000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Accumulated Depreciation: -7413000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Allowance For Doubtful Accounts Receivable: -62000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Amortization: 231000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Amortization Of Intangibles Income Statement: 231000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Basic Average Shares: 11585609911.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Basic EPS: 0.25
CSCO.TO cash_flow (quarterly, 2025-10-31) — Beginning Cash Position: 8910000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Capital Expenditure: -323000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Capital Stock: 48167000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 8400000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 15736000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Cash Dividends Paid: -1617000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Financing Activities: -3863000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Investing Activities: 156000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Operating Activities: 3212000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Change In Account Payable: -108000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Change In Accrued Expense: -539000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Change In Inventory: -234000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Change In Other Current Assets: -592000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Change In Other Current Liabilities: -374000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Change In Other Working Capital: -851000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Change In Payable: -108000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Change In Payables And Accrued Expense: -647000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Change In Receivables: 1545000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Change In Working Capital: -1153000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Changes In Account Receivables: 1857000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Changes In Cash: -495000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Commercial Paper: 3476000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Common Stock: 48167000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Common Stock Dividend Paid: -1617000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 46873000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Common Stock Payments: -2276000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Cost Of Revenue: 5138000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Current Assets: 32876000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Current Debt: 6725000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Current Debt And Capital Lease Obligation: 6725000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Current Deferred Liabilities: 15801000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Current Deferred Revenue: 15801000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Current Liabilities: 35451000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Deferred Income Tax: 25000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Deferred Tax: 25000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Depreciation: 606000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Depreciation Amortization Depletion: 606000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Depreciation Amortization Depletion Income Statement: 231000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Depreciation And Amortization: 606000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Depreciation And Amortization In Income Statement: 231000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Diluted Average Shares: 11693968750.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Diluted EPS: 0.25
CSCO.TO income_statement (quarterly, 2025-10-31) — Diluted NI Availto Com Stockholders: 2860000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — EBIT: 3741000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — EBITDA: 4347000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Effect Of Exchange Rate Changes: -14000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — End Cash Position: 8401000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Financing Cash Flow: -3863000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Finished Goods: 985000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Free Cash Flow: 2889000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Gain Loss On Sale Of Business: -178000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Gain On Sale Of Security: 190000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Gains Losses Not Affecting Retained Earnings: -930000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — General And Administrative Expense: 733000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Goodwill: 59119000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Goodwill And Other Intangible Assets: 67832000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Gross Accounts Receivable: 4889000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Gross PPE: 9661000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Gross Profit: 9745000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Income Tax Paid Supplemental Data: 634000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Income Tax Payable: 2471000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Interest Expense: 350000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Interest Expense Non Operating: 350000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Interest Income: 222000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Interest Income Non Operating: 222000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Interest Paid Supplemental Data: 616000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Inventory: 3395000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Invested Capital: 74962000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Investing Cash Flow: 156000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Issuance Of Debt: 1559000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Loans Receivable: 2714000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Long Term Debt: 21364000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 21364000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Long Term Debt Issuance: 1559000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Long Term Debt Payments: -2788000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Machinery Furniture Equipment: 5550000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Net Business Purchase And Sale: -7000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Net Common Stock Issuance: -2276000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Net Debt: 19689000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Net Income: 2860000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Net Income Common Stockholders: 2860000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Net Income Continuous Operations: 2860000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Net Income From Continuing And Discontinued Operation: 2860000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: 2860000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Net Income From Continuing Operations: 2860000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Net Income Including Noncontrolling Interests: 2860000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Net Interest Income: -128000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Net Investment Purchase And Sale: 508000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Net Issuance Payments Of Debt: 31000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Net Long Term Debt Issuance: -1229000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Net Non Operating Interest Income Expense: -128000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Net Other Financing Charges: -1000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Net Other Investing Changes: -22000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Net PPE: 2248000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Net PPE Purchase And Sale: -323000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Net Short Term Debt Issuance: 1260000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: -20959000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Non Current Accounts Receivable: 644000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Assets: 7314000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Liabilities: 12168000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Revenue: 12168000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Taxes Assets: 7314000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Non Current Note Receivables: 3075000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Normalized EBITDA: 4304000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Normalized Income: 2823733411.97
CSCO.TO cash_flow (quarterly, 2025-10-31) — Operating Cash Flow: 3212000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Operating Gains Losses: -178000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Operating Income: 3510000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Operating Revenue: 14883000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 3938000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Other Current Assets: 5833000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Other Current Borrowings: 3249000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Other Current Liabilities: 4972000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Other Equity Adjustments: -930000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Other Gand A: 733000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Other Income Expense: 9000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Other Intangible Assets: 8713000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Other Inventories: 5000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Other Non Cash Items: -3000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Other Non Current Assets: 7113000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Other Non Current Liabilities: 3074000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Other Non Operating Income Expenses: -34000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Other Properties: 49000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Other Receivables: 371000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Other Short Term Investments: 7336000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Payables: 4889000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Payables And Accrued Expenses: 4889000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Pensionand Other Post Retirement Benefit Plans Current: 3064000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Preferred Stock: 0.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Pretax Income: 3391000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Properties: 4062000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Purchase Of Business: -7000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Purchase Of Investment: -2002000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Purchase Of PPE: -323000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Raw Materials: 1994000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Receivables: 7912000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Reconciled Cost Of Revenue: 4763000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Reconciled Depreciation: 606000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Repayment Of Debt: -2788000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Repurchase Of Capital Stock: -2276000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Research And Development: 2400000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Restructuring And Mergern Acquisition: 147000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Retained Earnings: -364000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Sale Of Investment: 2510000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Selling And Marketing Expense: 2871000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Selling General And Administration: 3604000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Share Issued: 3938000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Special Income Charges: -147000000.00
CSCO.TO cash_flow (quarterly, 2025-10-31) — Stock Based Compensation: 1055000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Stockholders Equity: 46873000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Tangible Book Value: -20959000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Tax Effect Of Unusual Items: 6733411.97
CSCO.TO income_statement (quarterly, 2025-10-31) — Tax Provision: 531000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Tax Rate For Calcs: 0.16
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Total Assets: 121102000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Total Capitalization: 68237000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Total Debt: 28089000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Total Equity Gross Minority Interest: 46873000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Total Expenses: 11373000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Total Liabilities Net Minority Interest: 74229000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Total Non Current Assets: 88226000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Total Non Current Liabilities Net Minority Interest: 38778000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Total Operating Income As Reported: 3363000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Total Tax Payable: 2471000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Total Unusual Items: 43000000.00
CSCO.TO income_statement (quarterly, 2025-10-31) — Total Unusual Items Excluding Goodwill: 43000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Tradeand Other Payables Non Current: 2172000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Work In Process: 411000000.00
CSCO.TO balance_sheet (quarterly, 2025-10-31) — Working Capital: -2575000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — +Operating Expense: 6155000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — +Total Revenue: 15349000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Accounts Payable: 2762000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Accounts Receivable: 6606000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Accumulated Depreciation: -7354000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Allowance For Doubtful Accounts Receivable: -76000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Amortization: 231000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Amortization Of Intangibles Income Statement: 231000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Basic Average Shares: 11582681294.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Basic EPS: 0.27
CSCO.TO cash_flow (quarterly, 2026-01-31) — Beginning Cash Position: 8401000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Capital Expenditure: -283000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Capital Stock: 48493000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Cash And Cash Equivalents: 7458000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 15777000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Cash Dividends Paid: -1617000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Financing Activities: -1439000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Investing Activities: -1306000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Operating Activities: 1822000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Change In Account Payable: 344000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Change In Accrued Expense: 419000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Change In Inventory: -527000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Change In Other Current Assets: -50000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Change In Other Current Liabilities: 557000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Change In Other Working Capital: -1942000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Change In Payable: 344000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Change In Payables And Accrued Expense: 763000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Change In Receivables: -1611000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Change In Working Capital: -2810000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Changes In Account Receivables: -1803000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Changes In Cash: -923000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Commercial Paper: 5469000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Common Stock: 48493000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Common Stock Dividend Paid: -1617000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: 47723000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Common Stock Payments: -1079000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Cost Of Revenue: 5377000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Current Assets: 35131000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Current Debt: 8719000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Current Debt And Capital Lease Obligation: 8719000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Current Deferred Liabilities: 16199000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Current Deferred Revenue: 16199000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Current Liabilities: 36786000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Deferred Income Tax: -89000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Deferred Tax: -89000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Depreciation: 659000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Depreciation Amortization Depletion: 659000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Depreciation Amortization Depletion Income Statement: 231000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Depreciation And Amortization: 659000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Depreciation And Amortization In Income Statement: 231000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Diluted Average Shares: 11667611195.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Diluted EPS: 0.27
CSCO.TO income_statement (quarterly, 2026-01-31) — Diluted NI Availto Com Stockholders: 3175000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — EBIT: 4016000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — EBITDA: 4675000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Effect Of Exchange Rate Changes: -19000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — End Cash Position: 7459000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Financing Cash Flow: -1439000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Finished Goods: 987000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Free Cash Flow: 1539000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Gain Loss On Sale Of Business: -59000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Gain On Sale Of Security: 59000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Gains Losses Not Affecting Retained Earnings: -836000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — General And Administrative Expense: 688000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Goodwill: 59234000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Goodwill And Other Intangible Assets: 67541000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Gross Accounts Receivable: 6682000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Gross PPE: 9705000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Gross Profit: 9972000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Income Tax Paid Supplemental Data: 2935000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Income Tax Payable: 195000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Interest Expense: 370000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Interest Expense Non Operating: 370000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Interest Income: 210000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Interest Income Non Operating: 210000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Interest Paid Supplemental Data: 85000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Inventory: 3920000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Invested Capital: 77809000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Investing Cash Flow: -1306000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Issuance Of Debt: 2682000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Loans Receivable: 2634000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Long Term Debt: 21367000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Long Term Debt And Capital Lease Obligation: 21367000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Long Term Debt Issuance: 2682000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Long Term Debt Payments: -204000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Machinery Furniture Equipment: 5594000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Net Business Purchase And Sale: -39000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Net Common Stock Issuance: -725000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Net Debt: 22628000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Net Income: 3175000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Net Income Common Stockholders: 3175000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Net Income Continuous Operations: 3175000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Net Income From Continuing And Discontinued Operation: 3175000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: 3175000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Net Income From Continuing Operations: 3175000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Net Income Including Noncontrolling Interests: 3175000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Net Interest Income: -160000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Net Investment Purchase And Sale: -998000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Net Issuance Payments Of Debt: 1968000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Net Long Term Debt Issuance: 2478000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Net Non Operating Interest Income Expense: -160000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Net Other Financing Charges: -1065000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Net Other Investing Changes: 14000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Net PPE: 2351000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Net PPE Purchase And Sale: -283000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Net Short Term Debt Issuance: -510000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Net Tangible Assets: -19818000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Non Current Accounts Receivable: 541000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Assets: 7399000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Liabilities: 12204000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Revenue: 12204000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Taxes Assets: 7399000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Non Current Note Receivables: 3157000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Normalized EBITDA: 4652000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Normalized Income: 3154971201.32
CSCO.TO cash_flow (quarterly, 2026-01-31) — Operating Cash Flow: 1822000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Operating Gains Losses: -59000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Operating Income: 3817000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Operating Revenue: 15349000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Ordinary Shares Number: 3949000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Other Current Assets: 5884000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Other Current Borrowings: 3250000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Other Current Liabilities: 5417000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Other Equity Adjustments: -836000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Other Gand A: 688000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Other Income Expense: -11000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Other Intangible Assets: 8307000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Other Inventories: 6000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Other Non Current Assets: 7251000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Other Non Current Liabilities: 3167000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Other Non Operating Income Expenses: -34000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Other Properties: 51000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Other Receivables: 310000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Other Short Term Investments: 8319000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Payables: 2957000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Payables And Accrued Expenses: 2957000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 3494000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Preferred Stock: 0.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Pretax Income: 3646000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Properties: 4060000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Purchase Of Business: -39000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Purchase Of Investment: -2291000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Purchase Of PPE: -283000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Raw Materials: 2243000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Receivables: 9550000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Reconciled Cost Of Revenue: 4949000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Reconciled Depreciation: 659000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Repayment Of Debt: -204000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Repurchase Of Capital Stock: -1079000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Research And Development: 2355000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Restructuring And Mergern Acquisition: 36000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Retained Earnings: 66000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Sale Of Investment: 1293000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Selling And Marketing Expense: 2881000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Selling General And Administration: 3569000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Share Issued: 3949000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Special Income Charges: -36000000.00
CSCO.TO cash_flow (quarterly, 2026-01-31) — Stock Based Compensation: 934000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Stockholders Equity: 47723000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Tangible Book Value: -19818000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Tax Effect Of Unusual Items: 2971201.32
CSCO.TO income_statement (quarterly, 2026-01-31) — Tax Provision: 471000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Tax Rate For Calcs: 0.13
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Total Assets: 123371000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 69090000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Total Debt: 30086000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: 47723000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Total Expenses: 11532000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 75648000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Total Non Current Assets: 88240000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 38862000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Total Operating Income As Reported: 3781000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Total Tax Payable: 195000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Total Unusual Items: 23000000.00
CSCO.TO income_statement (quarterly, 2026-01-31) — Total Unusual Items Excluding Goodwill: 23000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Tradeand Other Payables Non Current: 2124000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Work In Process: 684000000.00
CSCO.TO balance_sheet (quarterly, 2026-01-31) — Working Capital: -1655000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — +Operating Expense: 6121000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — +Total Revenue: 15841000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Accounts Payable: 2970000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Accounts Receivable: 6480000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Accumulated Depreciation: -7281000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Allowance For Doubtful Accounts Receivable: -73000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Amortization: 228000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Amortization Of Intangibles Income Statement: 228000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Basic Average Shares: 11573895442.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Basic EPS: 0.29
CSCO.TO cash_flow (quarterly, 2026-04-30) — Beginning Cash Position: 7459000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Capital Expenditure: -414000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Capital Stock: 48950000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Cash And Cash Equivalents: 7083000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 16640000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Cash Dividends Paid: -1660000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Financing Activities: -2039000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Investing Activities: -2070000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Operating Activities: 3757000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Change In Account Payable: 208000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Change In Accrued Expense: -212000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Change In Inventory: -788000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Change In Other Current Assets: 40000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Change In Other Current Liabilities: -530000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Change In Other Working Capital: 310000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Change In Payable: 208000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Change In Payables And Accrued Expense: -4000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Change In Receivables: 219000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Change In Working Capital: -753000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Changes In Account Receivables: 133000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Changes In Cash: -352000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Commercial Paper: 8434000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Common Stock: 48950000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Common Stock Dividend Paid: -1660000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Common Stock Equity: 48861000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Common Stock Issuance: 0.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Common Stock Payments: -2612000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Cost Of Revenue: 5761000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Current Assets: 36559000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Current Debt: 11932000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Current Debt And Capital Lease Obligation: 11932000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Current Deferred Liabilities: 16446000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Current Deferred Revenue: 16446000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Current Liabilities: 39541000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Deferred Income Tax: -153000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Deferred Tax: -153000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Depreciation Amortization Depletion: 637000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Depreciation Amortization Depletion Income Statement: 228000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Depreciation And Amortization: 637000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Depreciation And Amortization In Income Statement: 228000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Diluted Average Shares: 11661753960.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Diluted EPS: 0.29
CSCO.TO income_statement (quarterly, 2026-04-30) — Diluted NI Availto Com Stockholders: 3373000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — EBIT: 4416000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — EBITDA: 5053000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Effect Of Exchange Rate Changes: -24000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — End Cash Position: 7083000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Financing Cash Flow: -2039000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Finished Goods: 1107000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Free Cash Flow: 3343000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Gain Loss On Sale Of Business: -263000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Gain On Sale Of Security: 268000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Gains Losses Not Affecting Retained Earnings: -793000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — General And Administrative Expense: 661000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Goodwill: 59292000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Goodwill And Other Intangible Assets: 67142000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Gross Accounts Receivable: 6553000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Gross PPE: 9858000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Gross Profit: 10080000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Income Tax Paid Supplemental Data: 659000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Income Tax Payable: 173000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Interest Expense: 377000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Interest Expense Non Operating: 377000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Interest Income: 214000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Interest Income Non Operating: 214000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Interest Paid Supplemental Data: 604000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Inventory: 4708000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Invested Capital: 80164000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Investing Cash Flow: -2070000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Issuance Of Capital Stock: 0.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Issuance Of Debt: 6399000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Loans Receivable: 2584000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Long Term Debt: 19371000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Long Term Debt And Capital Lease Obligation: 19371000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Long Term Debt Issuance: 6399000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Long Term Debt Payments: -4862000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Machinery Furniture Equipment: 5670000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Net Business Purchase And Sale: 0.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Net Common Stock Issuance: -2612000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Net Debt: 24220000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Net Income: 3373000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Net Income Common Stockholders: 3373000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Net Income Continuous Operations: 3373000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Net Income From Continuing And Discontinued Operation: 3373000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Net Income From Continuing Operation Net Minority Interest: 3373000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Net Income From Continuing Operations: 3373000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Net Income Including Noncontrolling Interests: 3373000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Net Interest Income: -163000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Net Investment Purchase And Sale: -1658000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Net Issuance Payments Of Debt: 1199000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Net Long Term Debt Issuance: 1537000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Net Non Operating Interest Income Expense: -163000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Net Other Financing Charges: 1034000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Net Other Investing Changes: 2000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Net PPE: 2577000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Net PPE Purchase And Sale: -414000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Net Short Term Debt Issuance: -338000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Net Tangible Assets: -18281000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Non Current Accounts Receivable: 518000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Assets: 7558000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Liabilities: 12153000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Revenue: 12153000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Taxes Assets: 7558000000.00
CSCO.TO balance_sheet (quarterly, 2026-04-30) — Non Current Note Receivables: 3124000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Normalized EBITDA: 4784000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Normalized Income: 3148356028.72
CSCO.TO cash_flow (quarterly, 2026-04-30) — Operating Cash Flow: 3757000000.00
CSCO.TO cash_flow (quarterly, 2026-04-30) — Operating Gains Losses: -263000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Operating Income: 3959000000.00
CSCO.TO income_statement (quarterly, 2026-04-30) — Operating Revenue: 15841000000.00